1. Home
  2. JAZZ vs HLI Comparison

JAZZ vs HLI Comparison

Compare JAZZ & HLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$194.31

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Logo Houlihan Lokey Inc.

HLI

Houlihan Lokey Inc.

HOLD

Current Price

$150.73

Market Cap

10.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAZZ
HLI
Founded
2003
1972
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
10.4B
10.6B
IPO Year
2007
2015

Fundamental Metrics

Financial Performance
Metric
JAZZ
HLI
Price
$194.31
$150.73
Analyst Decision
Strong Buy
Buy
Analyst Count
13
7
Target Price
$216.92
$194.29
AVG Volume (30 Days)
734.6K
585.5K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
1.58%
EPS Growth
N/A
41.61
EPS
N/A
4.74
Revenue
$1,618,693,000.00
$2,389,416,000.00
Revenue This Year
$6.13
$14.31
Revenue Next Year
$7.75
$12.52
P/E Ratio
N/A
$32.04
Revenue Growth
N/A
24.81
52 Week Low
$98.96
$134.41
52 Week High
$200.24
$211.78

Technical Indicators

Market Signals
Indicator
JAZZ
HLI
Relative Strength Index (RSI) 61.80 58.03
Support Level $159.78 $135.21
Resistance Level $198.00 $197.08
Average True Range (ATR) 4.75 4.03
MACD 0.67 2.34
Stochastic Oscillator 69.84 93.35

Price Performance

Historical Comparison
JAZZ
HLI

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About HLI Houlihan Lokey Inc.

Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.

Share on Social Networks: